Cargando…
639. Are SARS-CoV-2 antigenemia measurements still relevant? Comparison of Omicron era to early pandemic plasma nucleocapsid levels
BACKGROUND: Viral nucleocapsid in the blood (antigenemia) is a sensitive marker of acute COVID-19 and is supported in numerous published studies to have diagnostic and prognostic value. Review of the literature shows that nearly all antigenemia studies published as of February 25, 2023 precede the e...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677356/ http://dx.doi.org/10.1093/ofid/ofad500.703 |